Literature DB >> 2950338

Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke.

G Jürgens, P Költringer.   

Abstract

We estimated the serum levels of lipoprotein(a) [Lp(a)] of 87 patients suffering from ischemic cerebrovascular disease (ICVD) (50 men, 37 women; mean age, 66.7 +/- 10.9 years; median, 66) and of 66 healthy controls (33 men, 33 women; mean age, 62.2 +/- 11.1; median, 63). The Lp(a) serum levels of the ICVD group (mean, 20.5 +/- 23 mg/dl; median, 9.5) were significantly elevated compared with those of controls (mean, 14.2 +/- 23.1 mg/dl; median, 5). In a smaller subgroup, limiting the age range to 30 to 60 years, the difference in the Lp(a) serum levels between the ICVD patients and the controls was even highly significant (p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2950338     DOI: 10.1212/wnl.37.3.513

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Expressed hypervariable polymorphism of apolipoprotein (a).

Authors:  M I Kamboh; R E Ferrell; B A Kottke
Journal:  Am J Hum Genet       Date:  1991-11       Impact factor: 11.025

Review 2.  Lipoprotein(a): searching for a function.

Authors:  P C Harpel; M Poon; X Zhang; M B Taubman
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

3.  Reduction of Lp(a) by different methods of plasma exchange.

Authors:  I Schenck; C Keller; S Hailer; G Wolfram; N Zöllner
Journal:  Klin Wochenschr       Date:  1988-12-15

Review 4.  Lipoprotein (a) and stroke.

Authors:  H J Milionis; A F Winder; D P Mikhailidis
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

5.  Serum lipids in young patients with ischaemic stroke: a case-control study.

Authors:  J F Albucher; J Ferrieres; J B Ruidavets; B Guiraud-Chaumeil; B P Perret; F Chollet
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

6.  Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

Authors:  A Rosengren; L Wilhelmsen; E Eriksson; B Risberg; H Wedel
Journal:  BMJ       Date:  1990-12-01

7.  Apolipoprotein (a) concentrations and susceptibility to coronary artery disease in patients with peripheral vascular disease.

Authors:  P Groves; A Rees; A Bishop; R Morgan; M Ruttley; N Lewis; I Lane; R Hall
Journal:  Br Heart J       Date:  1993-01

8.  Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.

Authors:  P C Harpel; V T Chang; W Borth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  Elevated endothelin levels in patients with hyperlipoproteinemia.

Authors:  T Haak; W März; E Jungmann; S Hausser; R Siekmeier; W Gross; K H Usadel
Journal:  Clin Investig       Date:  1994-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.